Measles No Longer a Relic of the Past as Cases Fall Below Threshold in Several French Regions

First and foremost, a clarification is necessary: measles has never completely disappeared from French territory, contrary to a stubborn misconception. In a PMI waiting room in Marseille, a young mother hesitates to vaccinate her infant, convinced that this disease belongs to the past, relegated to history books alongside smallpox. Yet the numbers tell a very different story. In several regions of France, a key indicator has just crossed a threshold that epidemiologists watch as closely as milk on the fire. This retreat, still subtle to the general public, could well reopen a door that many believed was firmly closed.

A 95% threshold has become fragile in several regions

In France, MMR (measles, mumps, rubella) vaccination coverage remains broadly high on paper, but national averages mask worrying regional disparities. At 24 months, 94.3% of children have received their first dose and 91.3% the second, numbers that appear reassuring at first glance. The issue lies elsewhere: among 18-35-year-olds, declared coverage drops to 90.4% on average in mainland France, with sometimes marked regional gaps. And it is precisely this age group, often under-vaccinated or poorly informed about their immune status, that quietly fuels the virus’s circulation. The MMR vaccination coverage remains below the critical 95% threshold in several French regions, a decline that favors the emergence of localized epidemic clusters, comparable to those already observed across the Atlantic.

Why this rate of 95 % constitutes the epidemiological red line

This 95% figure is by no means arbitrary. It corresponds to the so-called herd immunity threshold, calculated based on the highly contagious nature of the measles virus, one of the most transmissible pathogens known today. A single sick individual can transmit the disease to between twelve and eighteen non-immunized people in their close circle, a reproductive rate that far exceeds that of many other infectious diseases. To break this chain of transmission and protect the most vulnerable (infants too young to be vaccinated, immunocompromised individuals), a very large portion of the population must be immune. As soon as vaccination coverage dips below this threshold, even by a few percentage points, the virus regains ground to circulate and spark localized outbreaks, sometimes in areas where the risk was thought to be under control for a long time.

The reasons for the decline in MMR vaccination in France

Several factors explain this gradual erosion of vaccination coverage. Vaccine hesitancy, fed by sometimes conflicting information circulating on social networks, continues to deter certain parents. Added to this is simple forgetfulness: many adults born before the broadening of the current vaccination schedule are unaware of their own immune status and do not think to catch up. Between January 1 and August 31, 2026, 113 measles cases were reported in France, including 41 hospitalizations and 17 complications, fortunately with no deaths recorded during this period. More telling still, among the cases targeted by vaccination whose status was known, 54% were not up to date with their boosters. This figure alone sums up the issue: it is not a problem of an ineffective vaccine, but of insufficient coverage.

The American precedent, mirror of a real health risk

What is unfolding in the United States currently provides a fairly clear idea of what can happen when vaccination coverage declines over time. The country is experiencing in 2026 its worst year since 1991, with nearly 3,887 confirmed cases and 42 new outbreak clusters recorded by October 1, compared with just 2,289 infections for all of 2025. Pennsylvania is experiencing the largest outbreak in more than thirty years, with five measles-related deaths already reported. New York State, for its part, declared a public health emergency in early October, with 108 cases recorded in just a few days. As a direct consequence of this surge, the international panel tasked with reassessing the United States’ elimination status for the disease postponed its meeting to November 2026. Canada, meanwhile, has already lost its status as a country that had eliminated measles by the end of 2025, triggering for the entire Americas region this loss of status. A scenario that, all else being equal, reminds us that vigilance is not negotiable.

The French zones most exposed to an epidemic outbreak

In France, thirty-four departments reported at least one measles case during the studied period, a figure that testifies to circulation already well established on the territory. Some areas concentrate more reports than others, notably:

• The Yvelines
• Hauts-de-Seine
• Moselle
• Haute-Savoie
• Paris

These territories, often urban or densely populated, bring together ideal conditions for rapid spread: substantial mixing, high mobility, but also sometimes local vaccination coverage below the national average. This does not mean these regions are better or worse prepared medically than others, but rather that the combination of population density and vaccination gaps creates a terrain more conducive to the emergence of clusters.

Levers to restore protective vaccination coverage

Closing this vaccination gap remains entirely feasible, and this is perhaps the most reassuring takeaway. Catch-up vaccination, at any age, remains a simple and accessible option for adults who are unaware of their immune status or who have only received a single dose in childhood. Treating physicians and vaccination centers can easily guide individuals toward serological testing or directly toward a catch-up injection, a quick and relatively unburdensome action. For younger people, strengthening information for families, especially about the two-dose schedule, constitutes a key lever to restore and sustain the 95% threshold. Local awareness campaigns, targeted at the most affected departments, could also play a decisive role in the months ahead.

Measles, therefore, is not a disease relegated to medical history books. It remains an opportunistic virus, ready to exploit the slightest gap in collective vaccination coverage. Checking one’s own immune status, and that of those around you, remains perhaps the simplest act to permanently close this slightly ajar door.